Annals On Call Podcast

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Dr. Peter Zimetbaum, a leading expert in cardiovascular medicine from Harvard, delves into the growing prevalence of atrial fibrillation and the emerging role of ablation therapy. He discusses a compelling meta-analysis that highlights ablation's advantages over medication in reducing long-term stroke risk. Zimetbaum also shares insights on the innovative pulse-field ablation technique, which ensures safer, quicker procedures. Additionally, he addresses the integration of ablation for patients with heart failure and the importance of anticoagulation decisions post-procedure.

Join Dr. Centor as he speaks with Kevin Kip, VP for Clinical Analytics at the University of Pittsburgh, and Anum Saeed, Assistant Professor of Cardiology at UPMC. They delve into the intriguing study comparing semaglutide and empagliflozin for type 2 diabetes, highlighting critical outcomes such as mortality and cardiovascular events. They break down complex topics like emulating clinical trials using electronic health records and discuss how demographic factors influence treatment adherence. Their insights pave the way for future diabetes treatment strategies.

Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.

Jordana Cohen, a nephrologist and clinical researcher at Penn, dives into the underutilization of screening for primary aldosteronism. She reveals that less than 2% of eligible individuals are tested and stresses the need for better diagnostic strategies. The conversation critiques current confirmatory testing methods and champions new approaches. Additionally, they discuss the rising use of mineralocorticoid blockers in hypertension treatment and compare options for resistant hypertension, highlighting effective alternatives like ameloride.

Dr. Centor discusses artificial intelligence-assisted urgent care with Dr. Zehavi Kugler.

Dr. Centor discusses pseudogout with Dr. Robert McLean.